CANAGLIFLOZIN, A SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT-2) BLOCKER, NORMALIZES BLOOD GLUCOSE WITHOUT AFFECTING SYSTEMIC BLOOD PRESSURE, OXIDATIVE STRESS, INTRARENAL ANGIOTENSINOGEN GENE EXPRESSION AND KIDNEY INJURY IN TYPE 1 DIABETIC MICE

被引:0
|
作者
Chan, John S. D. [1 ]
Chenier, Isabelle [1 ]
Ghosh, Anindya [1 ]
Wu, Chin-Han [1 ]
Lo, Chao-Sheng [1 ]
Zhao, Shuiling [1 ]
Chiasson, Jean-Louis [1 ]
Filep, Janos G. [2 ]
Ingelfinger, Julie R. [3 ]
Zhang, Shao-Ling [1 ]
机构
[1] CHUM, Res Ctr, Montreal, PQ, Canada
[2] Hop Maison Neuve Rosemont, Res Ctr, Montreal, PQ H1T 2M4, Canada
[3] Massachusetts Gen Hosp, Pediat Nephrol Unit, Boston, MA 02114 USA
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
SP374
引用
收藏
页码:214 / 214
页数:1
相关论文
共 50 条
  • [41] USE OF SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) INHIBITOR IN PATIENTS WITH DIABETES MELLITUS FREE CHRONIC KIDNEY DISEASE 2-3A STAGES: 1 YEAR OF EXPERIENCE
    Ivanov, Dmytro
    Bevzenko, Tetyana
    Kushnirenko, Stella
    Rotova, Svetlana
    Taran, Olena
    Ivanova, Mariia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [42] The effect of Ramadan fasting and continuing sodium-glucose co-transporter-2 (SGLT2) inhibitor use on ketonemia, blood pressure and renal function in Muslim patients with type 2 diabetes
    Shao, Yanli
    Lim, Gwyneth Joy
    Chua, Chin Lian
    Wong, Yip Fong
    Yeoh, Ester Chai Kheng
    Low, Serena Kiat Mun
    Sum, Chee Fang
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 142 : 85 - 91
  • [43] Comparative safety of sodium-glucose co-transporter 2 inhibitors in elderly patients with type 2 diabetes mellitus and diabetic kidney disease: a systematic review and meta-analysis
    Liu, Yi
    An, Chuan
    Liu, Peilong
    Yang, Fan
    Zhao, Quanlin
    RENAL FAILURE, 2023, 45 (01)
  • [44] Sodium Glucose Transporter Type 2 Inhibitor, Empagliflozin, Improves Vascular Stiffness in Female Diabetic Mice Independent of Blood Pressure Reduction
    Demarco, Vincent G.
    Aroor, Annayya
    Jia, Guanghong
    Nistala, Ravi
    Garro, Mona
    Meininger, Gerald
    Martinez-Lemus, Luis
    Whaley-Connell, Adam
    Mayoux, Eric
    DIABETES, 2016, 65 : A502 - A502
  • [45] Sodium-glucose co-transporter 2 inhibitors & glucagon-like peptide-1 receptor agonists, efficacy & safety in diabetic kidney transplant recipients
    Mahmoud, Tarek
    Yagan, Jude
    Hasan, Amal
    Gheith, Osama A.
    Mostafa, Mohamed
    Rida, Suzann
    El-Serwi, Nabil
    Shaker, Mohamad
    Khalid, Mahmoud
    CLINICAL TRANSPLANTATION, 2023, 37 (12)
  • [46] Effect of sodium-glucose co-transporter 2 inhibitor on contrast-induced acute kidney injury and prognosis in type 2 diabetes patients undergoing percutaneous coronary intervention
    Yang, Shicheng
    Hao, Huifang
    Zhai, Xiufeng
    Zhang, Peng
    Fu, Naikuan
    FRONTIERS IN MEDICINE, 2025, 12
  • [47] Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease A protocol for systematic review and meta-analysis
    Yu, Baisong
    Dong, ChunXia
    Hu, ZhiJuan
    Liu, Bing
    MEDICINE, 2021, 100 (08) : E24655
  • [48] Factors affecting prescription of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus with established cardiovascular disease/ chronic kidney disease in Hong Kong: a qualitative study
    Ng, Ngai Mui
    Ng, Yeung Shing
    Chu, Tsun Kit
    Lau, Phyllis
    BMC PRIMARY CARE, 2022, 23 (01):
  • [49] Factors affecting prescription of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus with established cardiovascular disease/ chronic kidney disease in Hong Kong: a qualitative study
    Ngai Mui Ng
    Yeung Shing Ng
    Tsun Kit Chu
    Phyllis Lau
    BMC Primary Care, 23
  • [50] ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with and without diabetes
    Gronda, Edoardo
    Napoli, Claudio
    Iacoviello, Massimo
    Urbinati, Stefano
    Caldarola, Pasquale
    Mannucci, Edoardo
    Colivicchi, Furio
    Gabrielli, Domenico
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0C) : C184 - C195